The USPTO published patent application US20260092252A1 for Netrin-1 mimetic peptide amphiphiles, which are self-assembling molecules that mimic the natural netrin-1 protein for therapeutic use. The application covers nanofibers displaying bioactive PAs and methods of treating central nervous system injury using these compositions.

For companies developing CNS therapeutics or peptide-based treatments, this published application represents a potential blocking patent that could affect freedom to operate in this technology space. The filing date was September 30, 2025, with Application No. 19345142. No immediate compliance actions are required, but R&D teams should review for potential IP conflicts.